funding
-
Evvy Secures $14M for Vaginal Healthcare Platform
Evvy’s $14 million funding round was led by Left Lane Capital and included participation from General Catalyst, LabCorp Venture Fund, RH Capital, Ingeborg Investments, G9 Ventures, Virtue and Amboy Street Ventures. In total, Evvy has raised $19 million.
-
Digital Health Funding Steadied in Q1 After a Year of Decline
Global funding for digital health companies finally stabilized in Q1 of this year. The sector raised $3.4 billion — this marks the first time the digital health world didn’t experience a quarter-over-quarter funding decline since Q4 of 2021. By holding steady, digital health startups defied the dwindling fundraising totals seen across the broader venture capital landscape, where funding dropped by 13% quarter-over-quarter.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
MedArrive Rakes In $8M for Home Care Platform
MedArrive’s new $8 million funding was led by Cobalt Ventures, a subsidiary of Blue Cross and Blue Shield of Kansas City. With the funding, the company will grow its team, as well as improve on its product and technology, said Dan Trigub, CEO and co-founder of MedArrive.
-
Consumer / Employer, Health Tech
Kindbody Secures $100M To Expand Fertility Services Into New Markets
Kindbody’s $100 million funding, announced last week, was led by Perceptive Advisors. It brings the company’s total equity and debt funding to more than $290 million and its valuation to $1.8 billion. It will use the money to add 10 new locations.
-
Consumer / Employer, Health Tech
Tuned Secures $3.5M To Grow Hearing Care Platform for Employers
The funding round was led by Distributed Ventures and included participation from Idealab NY and Elements Health Ventures. Tuned plans to use the funding to contract with more employers and third party administrators, said Danny Aronson, co-founder and CEO of the startup.
-
NY Innovation Report Shows Funding Plummet for Women’s Health; Biotech Startups Gain Interest
New York healthcare startups received $3.9 billion of funding in 2022, compared to $9 billion in 2021, according to a new DHNY report. Biotech startups represented 22% of total funding in 2022, a stark difference from women’s health only representing 2%.
-
Digital Health Insurance Provider Angle Health Pulls in $58M
The $58 million funding round was led by Portage and included participation from PruVen Capital, Wing Venture Capital and others. With the funding, Angle Health plans to expand into additional markets and grow its membership.
-
Former VA Secretary Teams up With Daughter to Launch Chronic Pain Care Startup
Override provides chronic pain patients with a care team that includes a pain physician, a physical therapist, a psychologist and a coach. The company has received $3.5 million in seed funding and has acquired Take Courage Coaching.
-
Viome Life Sciences snags $67M to expand DTC pipeline of at-home tests and wellness products
The funding was led by Bold Capital Group. Other investors of the company include Khosla Ventures, WestRiver Group and Glico. In total, Viome has raised more than $150 million.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Nimbus Therapeutics secures $125M in financing for clinical programs
This funding round was led by Bain Capital Life Sciences and SV Health Investors. They join existing investors, including Bill Gates and Access Biotechnology. The money will be used to support several clinical trials.
-
Artificial Intelligence, BioPharma
Flagship Pioneering’s Senda Bio secures $123M for new ‘programmable medicines’
Biotech startup Senda Biosciences is developing technology that yields a new type of medicine with two programming components: one directs the therapy to go to a particular destination in the body while the second tells the therapy what to do once it gets there. With the Series C financing, Senda aims to reach the clinic in 2024.
-
MedCity Influencers, Pharma, Consumer / Employer
The time is right: Another shot to end cancer as we know it
Government-funded initiatives such as the Cancer Moonshot support not only the primary science that often serves as a foundation for medical advances, but also ensure that patients with rare cancers are not overlooked.
-
CEO of cardiology startup declares that its tech could potentially cure heart failure
Ceryx’s device, Cysoni, is designed to pace the heart in rhythm with a person’s respiration, so that the heart rate and breathing are synced. This is typically the case for a healthy person, but for someone with heart failure, that link becomes severed, CEO Stuart Plant said.
-
Startup Ansa Bio lands $68M to go long with enzymes approach to DNA synthesis
The DNA currently used in genetic medicines research is synthesized by chemical methods. Ansa Biotechnologies employs faster and less expensive enzymes-based technology, and the startup has raised capital to scale up operations as it prepares to launch its service.
-
Pharma, BioPharma, Artificial Intelligence
Princeton spinout ArrePath gets $20M to combine AI, imaging in antibiotics R&D
Anti-infective drug discovery startup ArrePath has launched with $20 million in seed funding to advance the development of molecules that use a dual mechanism to kill bacteria. The Princeton University spinout says its approach could overcome the drug resistance bacteria are developing to currently available products.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
